Therapy Areas: Devices
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
18 May 2026 - Endospan, a pioneer in endovascular solutions for complex aortic pathologies, announced on Monday that it has been acquired by medical device company Artivion Inc (NYSE: AORT) following ...
AngioDynamics reports 24-month PRESERVE data showing durable NanoKnife outcomes in prostate cancer
13 May 2026 - Medical technology company AngioDynamics Inc (NASDAQ: ANGO) reported on Wednesday that the two-year results from the PRESERVE pivotal trial of its NanoKnife System demonstrated sustained...
Cepheid receives CE mark for IVDR‑compliant gastrointestinal PCR panel
Vector Science & Therapeutics secures three-year manufacturing partnership with MPP Group to expand peptide pipeline
11 May 2026 - Medical technology company Vector Science & Therapeutics (TSXV: PAIN) announced on Monday that it has entered a three-year development and manufacturing agreement with MPP Group LLC ...
Abingdon Health supports UK launch of LVOne stroke triage test
11 May 2026 - Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF) reported on Monday that its customer UpFront Diagnostics has commercially launched the LVOne stroke triage blood test in the UK following U...
Fesarius Therapeutics reports publication of DermiSphere hDRT data
1 May 2026 - Bioregenerative technology company FesariusTherapeutics Inc announced on Thursday the publication of its peer reviewed evidence of category leading speed of 'neodermis' formatio...